CD8A and metastatic melanoma: Notably, a recent study has shown that multifunctional CD8+ T cells that simultaneously express Th1 cytokines and/or CD107a as a marker for cytotoxic granules have a greater protective effect than monofunctional CD8+ T cells in a DC-based vaccine study against metastatic melanoma [41].